SCHEMBL566758

SCHEMBL566758

Cc1ccc(C=C(C=O)c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
MAPT P10636 2/20 0.51
CYP3A4 P08684 1/20 0.51
HPGD P15428 1/20 0.51
PTGS2 P35354 2/20 0.51
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
POLB P06746 1/20 0.47
TSHR P16473 1/20 0.47
CYP2A6 P11509 1/20 0.45
NQO2 P16083 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
CYP1B1 Q16678 1/20 0.43
VCP P55072 1/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL566757 1.00 ALDH1A1 (0.51) ALDH1A1MAPTCYP3A4HPGDPTGS2
SCHEMBL28593357 0.92 MAPT (0.56) ALDH1A1MAPTCYP3A4HPGDPTGS2
SCHEMBL30873529 0.90 NQO2 (0.53) ALDH1A1MAPTHPGDPTGS2CES2
SCHEMBL7995907 0.88 ALDH1A1 (0.54) ALDH1A1MAPTHPGDPOLBTSHR
SCHEMBL566814 0.88 ALDH1A1 (0.54) ALDH1A1MAPTHPGDPOLBTSHR
SCHEMBL566813 0.88 ALDH1A1 (0.54) ALDH1A1MAPTHPGDPOLBTSHR
Hydrochloric Acid SCHEMBL11771744 0.86 ALDH1A1 (0.52) ALDH1A1MAPTHPGDNPC1RAB9A
SCHEMBL22500964 0.83 MAOB (0.50) ALDH1A1MAPTCYP3A4PTGS2CES2
SCHEMBL20400451 0.83 MAOB (0.50) ALDH1A1MAPTCYP3A4PTGS2CES2
SCHEMBL9412429 0.83 MAOB (0.50) ALDH1A1MAPTCYP3A4PTGS2CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018210-B2 Methods for stimulating a hydrocarbon-bearing formation by perforating a wellbore and introducing an acidic composition in the wellbore DORF KETAL CHEMICALS FZE (AE) 2024-06-25 US claimed
US-20240191128-A1 Methods for Stimulating a Hydrocarbon-bearing Formation by Perforating a Wellbore and Introducing an Acidic Composition in the Wellbore DORF KETAL CHEMICALS FZE (AE) 2024-06-13 US claimed
US-20230125900-A1 Downhole Methods HSBC BANK MIDDLE EAST LIMITED (AE) 2023-04-27 US claimed
US-20230120003-A1 Methods for Stimulating a Hydrocarbon-bearing Formation by Perforating a Wellbore and Introducing an Acidic Composition in the Wellbore HSBC BANK MIDDLE EAST LIMITED (AE) 2023-04-20 US claimed
US-11591511-B2 Methods for stimulating a hydrocarbon-bearing formation by perforating a wellbore and introducing and acidic composition in the wellbore FLUID ENERGY GROUP LTD (CA) 2023-02-28 US claimed
US-20210238469-A1 CORROSION INHIBITOR WITH IMPROVED PERFORMANCE AT HIGH TEMPERATURES CAMERON INTERNATIONAL CORPORATION 2021-08-05 US claimed
US-20210230476-A1 Novel Downhole Methods And Compositions Used in Such HSBC BANK MIDDLE EAST LIMITED (AE) 2021-07-29 US claimed
US-11066749-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2021-07-20 US claimed
EP-3791008-A1 CORROSION INHIBITOR WITH IMPROVED PERFORMANCE AT HIGH TEMPERATURES Services Petroliers Schlumberger (FR) 2021-03-17 EP claimed
US-20200173034-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-06-04 US claimed
WO-2010119235-A1 CORROSION INHIBITOR COMPOSITIONS COMPRISING THE REACTION PRODUCT FORMED FROM AN ALDEHYDE WITH A THIOL AND/OR AN AMINE FUNCTIONALIZED RING STRUCTURE AND ASSOCIATED METHODS HALLIBURTON ENERGY SERVICES, INC. (US) 2010-10-21 WO claimed
US-20100261623-A1 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods HALLIBURTON ENERGY SERVICES, INC. 2010-10-14 US claimed
US-20100087340-A1 Methods and Compositions for Inhibiting Metal Corrosion HALLIBURTON ENERGY SERVICES, INC. 2010-04-08 US claimed
EP-2125989-A1 IMPROVED CORROSION-INHIBITING ADDITIVES, TREATMENT FLUIDS, AND ASSOCIATED METHODS Halliburton Energy Services, Inc. (US) 2009-12-02 EP claimed
US-20080227668-A1 Corrosion-inhibiting additives, treatment fluids, and associated methods HALLIBURTON ENERGY SERVICES, INC. 2008-09-18 US claimed
WO-2008110789-A1 IMPROVED CORROSION-INHIBITING ADDITIVES, TREATMENT FLUIDS, AND ASSOCIATED METHODS HALLIBURTON ENERGY SERVICES, INC. (US) 2008-09-18 WO claimed
US-20080227669-A1 Corrosion-inhibiting additives, treatment fluids, and associated methods HALLIBURTON ENERGY SERVICES, INC. 2008-09-18 US claimed
EP-1689911-A1 METHODS AND COMPOSITIONS FOR INHIBITING METAL CORROSION Halliburton Energy Services, Inc. (US) 2006-08-16 EP claimed
WO-2005054544-A1 METHODS AND COMPOSITIONS FOR INHIBITING METAL CORROSION HALLIBURTON ENERGY SERVICES, INC. (US) 2005-06-16 WO claimed
US-20050123437-A1 Methods and compositions for inhibiting metal corrosion HALLIBURTON ENERGY SERVICES, INC. 2005-06-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238469-A1 CORROSION INHIBITOR WITH IMPROVED PERFORMANCE AT HIGH TEMPERATURES AOC1, C5, C9 ALDH1A1 457/4885MAPT 4647/4885CYP3A4 1592/4885
US-20100261623-A1 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods MUC1, CA1, MGMT ALDH1A1 7/4885MAPT 976/4885CYP3A4 2296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.